Research output per year
Research output per year
Research output
Search results
-
2023
Correction:Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus
Otten, T., Riemsma, R., Wijnen, B., Armstrong, N., Stirk, L., Gordon, C., Ramaekers, B., Kleijnen, J., Joore, M. & Grimm, S., 4 Sept 2023, In: Pharmacoeconomics. 41, 11, p. 1551-1551 1 p.Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic
Open Access -
2022
Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Grimm, S. E., Witlox, W., Wolff, R., Chalker, A., Hiligsmann, M., Wijnen, B., Ahmadu, C., Ryder, S., Armstrong, N., Duffy, S., Syndikus, I., Kleijnen, J. & Joore, M. A., May 2022, In: Pharmacoeconomics. 40, 5, p. 575-575 1 p.Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic
Open Access -
2021
Correction to: Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases")
Grimm, S. E., Pouwels, X., Ramaekers, B. L. T., Wijnen, B., Knies, S., Grutters, J. & Joore, M. A., 19 Jul 2021, In: Orphanet Journal of Rare Diseases. 16, 1, 1 p., 320.Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic
Open Access